Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
712 Views
eMediNexus 27 January 2023
Photoaggravated atopic dermatitis (PAD) affects nearly 1.4% to 16% of patients with AD but remains inadequately characterized with limited published data.
The present study thus provides a detailed clinical and photobiological characterization of PAD. It used the data collected from 120 consecutive patients diagnosed with PAD and analyzed them.
The study observed:
This case series study shows that PAD affects patients of different ages and SPTs and is associated with substantially impaired quality of life. Thus, confirming PAD through phototesting may provide better-personalized patient care by identifying stimulating wavelengths, relevant photocontact allergies and appropriate photoprotection advice.
Source: Rutter KJ, Farrar MD, Marjanovic EJ, et al. Clinicophotobiological characterization of photoaggravated atopic dermatitis. JAMA Dermatol. 2022;158(9):1022-30.
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}..
Benefits of Resistance Training in Boosting Cardiometabolic Health in .....
Impact of Induction Timing on Maternal and Neonatal Outcomes..
UACR: A Risk Factor for Adverse Cardiovascular Outcomes in Type 2 Diab.....
COPD: A Potential Risk Factor for Herpes Zoster..
FDA Approves LEQSELVI for Severe Alopecia Areata..
{{Article_Title}}..
IMA Warns against 'Mixopathy' While Supporting Alternative Medicine..
Probe Ordered after Govt. Medicines Dumped in J-K's Rajouri..
Anxiety and Relationship Issues Dominate Mental Health Concerns in Delhi: Report..
Suspension of Six Doctors Sparks Strike at Bengal Medical College..
80 cm for Women, 90 cm for Men: New Waist Circumference Standards for Indias Women and Men..